European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - bluetongue-virus serotype-1 antigen, bluetongue virus serotype 8 antigen - immunologicals - sheep; cattle - sheepactive immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/ or 8 (combination of maximum 2 serotypes), active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1,2, 4 and/ or 8 (combination of maximum 2 serotypes), active immunisation of sheep to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/or 8 (combination of maximum 2 serotypes).cattleactive immunisation of cattle to prevent viraemia caused by bluetongue virus serotype 1, 2, 4 and/ or 8, and to reduce clinical signs caused by bluetongue virus serotypes when observed in this species: serotype 1, 4 and / or 8 (combination of maximum 2 serotypes).active immunisation of cattle to prevent viraemia caused by bluetongue virus serotype 1, 2, 4 and/ or 8, and to reduce clinical signs caused by bluetongue virus serotypes when observed in this species: serotype 1, 4 and / or 8 (combination of maximum 2 serotypes).active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/or 8 (combination of maximum 2 serotypes).

European Union - English - EMA (European Medicines Agency)

merial - bluetongue-virus serotype-1 antigen - immunologicals - sheep; cattle - active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotype 1.onset of immunity has been demonstrated three weeks after the primary vaccination course. the duration of immunity for cattle and sheep is one year after the primary vaccination course.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

boehringer ingelheim vetmedica gmbh - bluetongue virus - suspension for injection - inactivated viral vaccine - cattle, sheep

European Union - English - EMA (European Medicines Agency)

merial - bluetongue virus serotype 8 antigen - immunologicals for ovidae, immunologicals for bovidae - sheep; cattle - active immunisation of sheep and cattle to prevent viraemia* and to reduce clinical signs caused by bluetongue virus serotype 8.*(below the level of detection by the validated rt-pcr method at 3.14log10 rna copies/ml, indicating no infectious virus transmission).onset of immunity has been demonstrated 3 weeks after the primary vaccination course.the duration of immunity for cattle and sheep is 1 year after the primary vaccination course.the duration of immunity is not yet fully established in cattle or sheep, although interim results of ongoing studies demonstrate that the duration is at least 6 months after the primary vaccination course in sheep.

European Union - English - EMA (European Medicines Agency)

cz veterinaria s.a. - bluetongue virus vaccine serotypes 1 or 4 or 8 [inactivated] - immunologicals - sheep, cattle - sheepactive immunisation against bluetongue virus serotype 8 to prevent viraemia and to reduce clinical signs.onset of immunity: 20 days after second dose.duration of immunity: 1 year after second dose.cattleactive immunisation against bluetongue virus serotype 8 to prevent viraemia.onset of immunity: 31 days after second dose.duration of immunity: 1 year after second dose.

European Union - English - EMA (European Medicines Agency)

cz veterinaria s.a. - bluetongue virus vaccine serotypes 1 or 4 or 8 [inactivated] - immunologicals - sheep, cattle - sheepactive immunisation against bluetongue virus serotype 8 to prevent viraemia and to reduce clinical signs.onset of immunity: 20 days after second dose.duration of immunity: 1 year after second dose.cattleactive immunisation against bluetongue virus serotype 8 to prevent viraemia.onset of immunity: 31 days after second dose.duration of immunity: 1 year after second dose.

European Union - English - EMA (European Medicines Agency)

intervet international bv - bluetongue virus vaccine, serotype 8 (inactivated) - inactivated viral vaccines, bluetongue virus, sheep - sheep; cattle - cattle to stimulate active immunity in sheep from 6 weeks of age against bluetongue virus serotype 8 to reduce viraemia sheep to stimulate active immunity in sheep from 1 month of age against bluetongue virus serotype 8 to prevent viraemia,

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - bluetongue virus vaccine, serotype 8 (inactivated) - immunologicals for ovidae - cattle; sheep - sheepfor the active immunisation of sheep from 2.5 months of age to prevent viraemia* and to reduce clinical signs caused by bluetongue virus serotype 8.cattlefor the active immunisation of cattle from 2.5 months of age to prevent viraemia* caused by bluetongue virus serotype 8.*(cycling value (ct) ≥ 36 by a validated rt-pcr method, indicating no presence of viral genome)

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cz vaccines s.a.u. - bluetongue virus serotype 4 (inactivated) - suspension for injection - blue tongue virus serotype 4, inactivated - bluetongue virus; qi04aa02 bluetongue virus - sheep; cattle

United Kingdom - English - VMD (Veterinary Medicines Directorate)

laboratorios syva s.a.u - bluetongue virus -